🏛️ Verified NIH Record • Updated 2026-07-17
Niraparib in Tumors Metastatic to the CNS (NCT04992013)
Genomically Guided Phase II Study to Evaluate the Clinical Benefit of Niraparib in Tumors Metastatic to the CNS
🔵 Active, Not Recruiting Phase2 💊 Investigational Drug / Biologic Sponsor: Massachusetts General Hospital
🩺 Plain-English Summary (8th-Grade Level)
This research is being done to see how effective the drug niraparib is against cancer that has metastasized to the central nervous system (CNS). * This research study involves the study drug niraparib.
Who can join: Review the eligibility criteria below.
Location: Massachusetts General Hospital Cancer Center — Boston, Massachusetts
Age range: 18 Years
🧪 Interventions in This Study
📋 "Do I Qualify?" — 1-Minute Self Screener
Instant ChecklistFull eligibility criteria are available on the official NIH protocol. View the criteria ↗
📍 All Participating Trial Locations (1 Sites)
- Massachusetts General Hospital Cancer Center — Boston, Massachusetts
💰 Cost, Insurance & Patient Rights
- 100% Free Items: The investigational treatment and protocol-required procedures are supplied at zero cost by the sponsor.
- Routine Patient Care: Under federal law (ACA § 2709) and many state statutes, routine care costs are covered during participation.
- Voluntary Participation: You may withdraw at any time without affecting your standard medical care.
More studies in Metastatic Cancer
- A Study of Several Radiation Doses for Patients With Progression on Immunotherapy/Checkpoint Inhibitors — Hartford, Connecticut
- Stereotactic Radiotherapy for Oligo-Progressive Metastatic Cancer (The STOP Trial) — Edmonton, Alberta
- A Study of Stereotactic Body Radiotherapy (SBRT) and Surgical Stabilization for People With Cancer That Has Spread to the Bone — Basking Ridge, New Jersey
- An Intervention to Help Patients and Caregivers Manage Stress and Improve Communication Skills When Talking About Cancer — New York, New York
- CSB-321 Ph 1 in Immunotherapy for the Treatment of Cancer — Boston, Massachusetts
Explore by condition: All Metastatic Cancer clinical trials
💡 How to Participate
- Check the checklist above to see if you may qualify.
- Review the official NIH record below to find the coordinating site.
- Ask about the visit schedule, what is covered at no cost, and any travel support.
- Confirm with your own doctor before making a decision.